Our mission is to integrate AI and the human intelligence to optimize patient outcomes
Revolutionizing Cancer Diagnosis with AI
As a global medical AI frontrunner, Deep Bio is dedicated to integrating AI into current pathology workflows to increase diagnostic accuracy and reduce turnaround times. We develop and implement deep learning-based software that can help medical professionals optimize their treatment decisions. Dedicated to developing innovative solutions in the digital healthcare sector, we have active collaborations with renowned universities and laboratories around the world.
Revolutionizing Cancer Diagnosis with AI
As a global medical AI frontrunner, Deep Bio is dedicated to integrating AI into current pathology workflows to increase diagnostic accuracy and reduce turnaround times. We develop and implement deep learning-based software that can help medical professionals optimize their treatment decisions. Dedicated to developing innovative solutions in the digital healthcare sector, we have active collaborations with renowned universities and laboratories around the world.
Standardizing Quality Diagnosis
Pathology has been facing major challenges to meet the increasing demands in cancer diagnoses, mainly due to the decreasing number of pathologists and increasing number of cases for early detection of cancer.
Allowing fast and timely diagnoses for patients and appropriate follow up care at the right time can hugely impact patient survival in some cases. And in moderate cases where only active surveillance is mandated, with the help of AI’s support for faster diagnoses, patients can be relieved of the anxiety in waiting for the final diagnoses early, which can take weeks.
To tackle another challenge pathology is facing, inconsistency and discordance in diagnoses, AI supports pathologists to make more consistent diagnoses with accurate metrics, such as tumor ratio out of the total tissue area and ratios of particular regions(patterns) out of the total tumor area, etc.
Unlocking New Insights in Cancer Medicine
Deep Bio’s first cancer diagnostic algorithm is for the detection and grading of prostate cancer on prostate core needle biopsy samples. Now we are expanding prostate specimen types to TURP (Transurethral Resection of the Prostate) and whole mount, as well as different cancer types to breast, lymph node metastasis, and bladder.
In addition to diagnostic solutions, we plan to develop algorithms to encompass the treatment paradigm such as AI software for patient stratification and prognosis prediction. These algorithms will enable the right diagnosis to be translated into the right personalized treatment to optimize patient outcomes.
Unlocking New Insights in Cancer Medicine
Deep Bio’s first cancer diagnostic algorithm is for the detection and grading of prostate cancer on prostate core needle biopsy samples. Now we are expanding prostate specimen types to TURP (Transurethral Resection of the Prostate) and whole mount, as well as different cancer types to breast, lymph node metastasis, and bladder.
In addition to diagnostic solutions, we plan to develop algorithms to encompass the treatment paradigm such as AI software for patient stratification and prognosis prediction. These algorithms will enable the right diagnosis to be translated into the right personalized treatment to optimize patient outcomes.
